JOURNAL OF ECT, cilt.26, sa.2, ss.104-110, 2010 (SCI-Expanded)
Objective: Relapse rates after electroconvulsive therapy (ECT) remain high with standard treatments. We aimed to test the efficacy of an early administered continuation pharmacotherapy (c-pharm early) strategy in prevention of post-ECT relapse.